Suppr超能文献

环磷酰胺和高剂量类固醇在瘢痕性类天疱疮性眼病中的作用。

Role of cyclophosphamide and high dose steroid in ocular cicatricial pemphigoid.

作者信息

Elder M J, Lightman S, Dart J K

机构信息

Moorfields Eye Hospital, London.

出版信息

Br J Ophthalmol. 1995 Mar;79(3):264-6. doi: 10.1136/bjo.79.3.264.

Abstract

AIMS/BACKGROUND: Ocular cicatricial pemphigoid (OCP) can present with severe conjunctival inflammation that requires systemic immunosuppression to avoid serious ocular morbidity. This study aimed to assess the clinical response to cyclophosphamide and short term, high dose prednisolone in this group of patients.

METHODS

A prospective, unmasked study assessed patients presenting with either 'severe' ocular inflammation (n = 4) or 'marked' or 'severe' ocular inflammation that had failed to respond to other systemic immunosuppression (n = 6). Nineteen inflamed eyes of 10 consecutive patients were enrolled.

RESULTS

The ocular inflammation resolved in 15 eyes in a mean time of 2.4 months. Two eyes perforated despite treatment and one patient was unable to tolerate the medication. Progressive cicatrisation occurred in 21%.

CONCLUSION

Cyclophosphamide and short term, high dose prednisolone are effective in severe inflammation caused by OCP but may not completely prevent cicatrisation.

摘要

目的/背景:眼部瘢痕性类天疱疮(OCP)可表现为严重的结膜炎症,需要全身免疫抑制以避免严重的眼部并发症。本研究旨在评估环磷酰胺和短期大剂量泼尼松龙对该组患者的临床疗效。

方法

一项前瞻性、非盲研究评估了出现“严重”眼部炎症的患者(n = 4)或对其他全身免疫抑制无反应的“显著”或“严重”眼部炎症患者(n = 6)。纳入了连续10例患者的19只发炎眼睛。

结果

15只眼睛的眼部炎症在平均2.4个月内消退。尽管进行了治疗,仍有2只眼睛穿孔,1例患者无法耐受该药物。21%的患者出现进行性瘢痕形成。

结论

环磷酰胺和短期大剂量泼尼松龙对OCP引起的严重炎症有效,但可能无法完全预防瘢痕形成。

相似文献

1
Role of cyclophosphamide and high dose steroid in ocular cicatricial pemphigoid.
Br J Ophthalmol. 1995 Mar;79(3):264-6. doi: 10.1136/bjo.79.3.264.
2
Sulphapyridine--a new agent for the treatment of ocular cicatricial pemphigoid.
Br J Ophthalmol. 1996 Jun;80(6):549-52. doi: 10.1136/bjo.80.6.549.
3
The effect of treatment and its related side effects in patients with severe ocular cicatricial pemphigoid.
Ophthalmology. 2002 Jan;109(1):111-8. doi: 10.1016/s0161-6420(01)00863-6.
4
Ocular Cicatricial Pemphigoid: Camouflaged as Persistent Conjunctivitis.
J Coll Physicians Surg Pak. 2019 Jun;29(6):S34-S36. doi: 10.29271/jcpsp.2019.06.S34.
5
Methotrexate therapy for ocular cicatricial pemphigoid.
Ophthalmology. 2004 Apr;111(4):796-801. doi: 10.1016/j.ophtha.2003.07.010.
6
[Ocular Cicatricial Pemphigoid - a Retrospective Study].
Cesk Slov Oftalmol. 2016 Feb;72(1):283-92.
7
Systemic chemotherapy for ocular cicatricial pemphigoid.
Cornea. 1991 May;10(3):185-95. doi: 10.1097/00003226-199105000-00001.
8
Control of ocular disease in mucous membrane pemphigoid.
Klin Monbl Augenheilkd. 2014 Apr;231(4):331-4. doi: 10.1055/s-0034-1368290. Epub 2014 Apr 25.
9
[Ocular cicatricial pemphigoid. Retrospective analysis of risk factors and complications].
Ophthalmologe. 2000 Feb;97(2):113-20. doi: 10.1007/s003470050021.
10
Ocular cicatricial pemphigoid: manifestations and management.
Curr Allergy Asthma Rep. 2005 Jul;5(4):333-8. doi: 10.1007/s11882-005-0078-9.

引用本文的文献

1
Oral cyclophosphamide monotherapy in advanced resistant ocular cicatricial pemphigoid.
Taiwan J Ophthalmol. 2024 Nov 6;15(2):290-296. doi: 10.4103/tjo.TJO-D-24-00057. eCollection 2025 Apr-Jun.
2
[Ocular mucous membrane pemphigoid].
Ophthalmologie. 2023 Jul;120(7):779-790. doi: 10.1007/s00347-023-01880-y. Epub 2023 Jun 15.
3
Rituximab Therapy for Mucous Membrane Pemphigoid: A Retrospective Monocentric Study With Long-Term Follow-Up in 109 Patients.
Front Immunol. 2022 Jun 30;13:915205. doi: 10.3389/fimmu.2022.915205. eCollection 2022.
5
Ocular Mucous Membrane Pemphigoid: Current State of Pathophysiology, Diagnostics and Treatment.
Ophthalmol Ther. 2019 Mar;8(1):5-17. doi: 10.1007/s40123-019-0164-z. Epub 2019 Jan 29.
6
The 2016 Bowman Lecture Conjunctival curses: scarring conjunctivitis 30 years on.
Eye (Lond). 2017 Feb;31(2):301-332. doi: 10.1038/eye.2016.284. Epub 2017 Jan 20.
8
Cyclophosphamide for ocular inflammatory diseases.
Ophthalmology. 2010 Feb;117(2):356-65. doi: 10.1016/j.ophtha.2009.06.060. Epub 2009 Dec 6.
9
Treatment strategies in mucous membrane pemphigoid.
Ther Clin Risk Manag. 2008 Jun;4(3):617-26. doi: 10.2147/tcrm.s1140.
10
[Mucous membrane pemphigoid with ocular involvement. Part II: therapy].
Ophthalmologe. 2008 Apr;105(4):405-19. doi: 10.1007/s00347-008-1700-8.

本文引用的文献

1
The conjunctiva in acute and chronic mucous membrane pemphigoid. An immunohistochemical analysis.
Ophthalmology. 1993 Mar;100(3):339-46. doi: 10.1016/s0161-6420(93)31644-1.
2
Immunosuppressive therapy for progressive ocular cicatricial pemphigoid.
Ophthalmology. 1982 Apr;89(4):340-53. doi: 10.1016/s0161-6420(82)34791-0.
3
Treatment of cicatricial (benign mucous membrane) pemphigoid with dapsone.
J Am Acad Dermatol. 1982 Feb;6(2):215-23. doi: 10.1016/s0190-9622(82)70014-3.
4
Ocular cicatricial pemphigoid.
Ophthalmology. 1981 Feb;88(2):95-100. doi: 10.1016/s0161-6420(81)35069-6.
5
Immunosuppressive therapy in ocular cicatricial pemphigoid.
Am J Ophthalmol. 1983 Oct;96(4):453-9. doi: 10.1016/s0002-9394(14)77908-5.
6
Benign mucous membrane pemphigoid.
Arch Dermatol. 1971 Nov;104(5):467-75.
8
Immunosuppressive and cytotoxic drugs in dermatology.
Arch Dermatol. 1974 Sep;110(3):393-406.
9
Cicatricial pemphigoid.
Trans Am Ophthalmol Soc. 1986;84:527-663.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验